Zum Heilen announces patent for cardamom-based nutraceutical Recovereez EP News Bureau Sep 18, 2023 Launches Recovereez at the World Spice Congress
Scientists investigate if prostate drug could also treat breast cancer that’s spread to the bone EP News Bureau Aug 25, 2023 When breast cancer cells spread to other parts of the body it is called secondary or metastatic breast cancer and although…
Glenmark reduces cost of Trastuzumab treatment in India EP News Bureau Jun 15, 2023 A 440 mg vial of Trumab will be priced at Rs 15,749, which makes it the most affordable option available currently in the country
Alembic Pharma gets USFDA nod for Docetaxel Injection USP EP News Bureau Mar 1, 2023 Docetaxcel Injections are indicated for breast cancer, non-small cell lung cancer, castration-resistant prostate cancer, gastric…
NATCO announces ANDA filing for generic olaparib tablets in US EP News Bureau Feb 13, 2023 Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic and prostrate cancer
Alembic Pharma gets USFDA nod for Fulvestrant injection, 250 mg/5 mL per single-dose syringe EP News Bureau Dec 26, 2022 Fulvestrant injection is an estrogen receptor antagonist indicated for the treatment of breast cancer
Israeli scientists find promising target for breast cancer and other cancer therapeutics EP News Bureau Jun 19, 2021 Our perception of the specific multistep molecular mechanistic process which regulates cancer initiation and progression found in…
Sanofi partners with BIG, EORTC, AFT to study amcenestrant for ER+ breast cancer treatment EP News Bureau Jun 4, 2021 Amcenestrant is an oral SERD that antagonises and degrades the estrogen receptor (ER), resulting in inhibition of the ER signaling…
NATCO gets US FDA nod for Everolimus tablets EP News Bureau Mar 8, 2021 They are indicated in the treatment of breast cancer and a few other types of cancers
USFDA denies application from SPARC for cancer drug Press Trust of India Feb 24, 2021 The Office of New Drugs of the US FDA requested the conduct of a new Phase 3 study in metastatic breast cancer patients to support…